Practical implication
Surgifrance must implement corrective actions, including the establishment of processes for handling complaints in 3 months, and a complaints register within 8 months.
The French national drug safety agency (ANSM) issued an injunction to Surgifrance requiring immediate corrective actions to enhance regulatory compliance and inspection readiness, including the establishment of verification processes, a complaints register, and a system for handling complaints and vigilance.
What changed: Surgifrance is mandated to rectify identified non-conformities, secure all required regulatory documents before marketing, and establish required processes within specified timelines.
Why it matters: This injunction is crucial for ensuring compliance with regulatory requirements, enhancing product safety, and preparing the establishment for upcoming inspections.
Practical implication: Surgifrance must implement corrective actions, including the establishment of processes for handling complaints in 3 months, and a complaints register within 8 months.
View original source
- Source: ANSM (France) - News feed
- Published at source: 2026-09-02T00:00:00.000Z
- Discovered by monitor: 2026-09-02T21:40:23.168Z
Published from the regulator source ingestion pipeline after PV impact triage.
